Affordable Access

deepdyve-link
Publisher Website

Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention.

Authors
  • Liu, Yong
  • Liu, Yuan-hui
  • Tan, Ning
  • Chen, Ji-yan
  • Zhou, Ying-ling
  • Li, Li-wen
  • Duan, Chong-yang
  • Chen, Ping-yan
  • Luo, Jian-fang
  • Li, Hua-long
Type
Published Article
Journal
PLoS ONE
Publisher
Public Library of Science
Publication Date
Jan 01, 2014
Volume
9
Issue
10
Identifiers
DOI: 10.1371/journal.pone.0111124
PMID: 25357250
Source
Medline
License
Unknown

Abstract

Rosuvastatin and atorvastatin have similar efficacies for preventing CIN in patients with CKD undergoing PCI.

Report this publication

Statistics

Seen <100 times